Independent minds. Global perspective. A publication for the builders
Biotechnology / San Francisco

Malhar Bhide.

Co-founder
Origin

Malhar Bhide co-founded Origin, which currently produces patient-derived cancer datasets for research customers. His public biography describes software and machine-learning work. The company's own laboratory processes samples into matched biological, imaging, and clinical information, providing data for pharmaceutical and AI-development workflows rather than a patient-facing treatment.

Public-source researchLast checked 1 source ↘
THE STORY, IN CONTEXT

Malhar Bhide and the story of Origin.

Origin's current description centers on preparing real-world datasets from laboratory samples. Its earlier public launch instead concerned designing regulatory DNA sequences for cell and gene therapies. These are distinct product directions within the supplied record, and the material does not explain the transition in full. The evidence supports a current data-production overview without independently validating model comparisons, therapeutic safety, or clinical translation from either line of work.

FROM THE PUBLIC RECORD

Public advice & further reading.

No personal advice is attributed in this profile: a verifiable public advice source has not yet been established. The company and activity facts above remain separately sourced.

Suggest a first-person interview or essay ↗
EVIDENCE IN PLAIN SIGHT

Sources & attribution.

  1. 01
    Origin — Y Combinator company and active founder profile

    Public active-founder biography, current company status and description, and founding-team launch accounts. Company or team statements are attributed accounts, not independently audited performance results.

    www.ycombinator.com
About this profile

Independently researched from the public sources above. Featured people and companies are not affiliated with BusinessBlogz. Source dates and attribution provide context for the information shown; business claims remain attributed to their original source. Role and company details can change after review. The initials graphic is editorial artwork, not a photograph.

Request a correction or update ↗
KEEP EXPLORING

More builders in Biotechnology.

Explore the sector ↗